118 related articles for article (PubMed ID: 18687738)
1. Utility of kallikrein-related peptidases (KLKs) as cancer biomarkers.
Emami N; Diamandis EP
Clin Chem; 2008 Oct; 54(10):1600-7. PubMed ID: 18687738
[TBL] [Abstract][Full Text] [Related]
2. Kallikrein-Related Peptidases in Prostate Cancer: From Molecular Function to Clinical Application.
Fuhrman-Luck RA; Loessner D; Clements JA
EJIFCC; 2014 Oct; 25(3):269-81. PubMed ID: 27683474
[TBL] [Abstract][Full Text] [Related]
3. The roles of proteases in prostate cancer.
Koistinen H; Kovanen RM; Hollenberg MD; Dufour A; Radisky ES; Stenman UH; Batra J; Clements J; Hooper JD; Diamandis E; Schilling O; Rannikko A; Mirtti T
IUBMB Life; 2023 Jun; 75(6):493-513. PubMed ID: 36598826
[TBL] [Abstract][Full Text] [Related]
4. Kallikrein-related peptidase's significance in Alzheimer's disease pathogenesis: A comprehensive survey.
Boumali R; Urli L; Naim M; Soualmia F; Kinugawa K; Petropoulos I; El Amri C
Biochimie; 2024 Apr; ():. PubMed ID: 38608749
[TBL] [Abstract][Full Text] [Related]
5. Involvement of Kallikrein-Related Peptidases in Nervous System Disorders.
Mella C; Figueroa CD; Otth C; Ehrenfeld P
Front Cell Neurosci; 2020; 14():166. PubMed ID: 32655372
[TBL] [Abstract][Full Text] [Related]
6. Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs.
Maeda H; Khatami M
Clin Transl Med; 2018 Mar; 7(1):11. PubMed ID: 29541939
[TBL] [Abstract][Full Text] [Related]
7. Safety concerns and hidden agenda behind HPV vaccines: another generation of drug-dependent society?
Khatami M
Clin Transl Med; 2016 Dec; 5(1):46. PubMed ID: 27921284
[TBL] [Abstract][Full Text] [Related]
8. Comparison of two multiplexed technologies for profiling >1,000 serum proteins that may associate with tumor burden.
Ren A; Prassas I; Sugumar V; Soosaipillai A; Bernardini M; Diamandis EP; Kulasingam V
F1000Res; 2021; 10():509. PubMed ID: 34868557
[No Abstract] [Full Text] [Related]
9. Acteoside as a potential therapeutic option for primary hepatocellular carcinoma: a preclinical study.
Ma D; Wang J; Liu L; Chen M; Wang Z
BMC Cancer; 2020 Sep; 20(1):936. PubMed ID: 32993568
[TBL] [Abstract][Full Text] [Related]
10. Human Tissue Kallikreins in Polymorphous Adenocarcinoma: A Polymerase Chain Reaction and Immunohistochemical Study.
Cox J; Khan Z; Jackson-Boeters L; Armstrong J; Darling M
Head Neck Pathol; 2021 Mar; 15(1):169-178. PubMed ID: 32592124
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of p53 through induction of MDM2 degradation: Amino acid prodrugs of anthraquinone analogs.
Anifowose A; Yuan Z; Yang X; Pan Z; Zheng Y; Zhang Z; Wang B
Bioorg Med Chem Lett; 2020 Jan; 30(2):126786. PubMed ID: 31753697
[TBL] [Abstract][Full Text] [Related]
12. Quantitative assessment and clinical relevance of kallikrein-related peptidase 5 mRNA expression in advanced high-grade serous ovarian cancer.
Gong W; Liu Y; Seidl C; Diamandis EP; Kiechle M; Drecoll E; Kotzsch M; Magdolen V; Dorn J
BMC Cancer; 2019 Jul; 19(1):696. PubMed ID: 31307411
[TBL] [Abstract][Full Text] [Related]
13. microRNA-205 and microRNA-338-3p Reduces Cell Apoptosis in Prostate Carcinoma Tissue and LNCaP Prostate Carcinoma Cells by Directly Targeting the B-Cell Lymphoma 2 (Bcl-2) Gene.
Zhang X; Pan Y; Fu H; Zhang J
Med Sci Monit; 2019 Feb; 25():1122-1132. PubMed ID: 30741252
[TBL] [Abstract][Full Text] [Related]
14. Discovery, Synthesis, Pharmacological Profiling, and Biological Characterization of Brintonamides A-E, Novel Dual Protease and GPCR Modulators from a Marine Cyanobacterium.
Al-Awadhi FH; Gao B; Rezaei MA; Kwan JC; Li C; Ye T; Paul VJ; Luesch H
J Med Chem; 2018 Jul; 61(14):6364-6378. PubMed ID: 30015488
[TBL] [Abstract][Full Text] [Related]
15. Validity of Prostate Health Index and Percentage of [-2] Pro-Prostate-Specific Antigen as Novel Biomarkers in the Diagnosis of Prostate Cancer: Omani Tertiary Hospitals Experience.
Al Saidi SS; Al Riyami NB; Al Marhoon MS; Al Saraf MS; Al Busaidi SS; Bayoumi R; Mula-Abed WS
Oman Med J; 2017 Jul; 32(4):275-283. PubMed ID: 28804579
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of multiple kallikreins in high-grade astrocytoma.
Drucker KL; Gianinni C; Decker PA; Diamandis EP; Scarisbrick IA
BMC Cancer; 2015 Aug; 15():565. PubMed ID: 26231762
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of human tissue kallikrein-related peptidases 11 and 15 in gastric cancer.
Kolin DL; Sy K; Rotondo F; Bassily MN; Kovacs K; Brezden-Masley C; Streutker CJ; Yousef GM
Tumour Biol; 2016 Jan; 37(1):437-46. PubMed ID: 26224476
[TBL] [Abstract][Full Text] [Related]
18. A Highly Sensitive Porous Silicon (P-Si)-Based Human Kallikrein 2 (hK2) Immunoassay Platform toward Accurate Diagnosis of Prostate Cancer.
Lee SW; Hosokawa K; Kim S; Jeong OC; Lilja H; Laurell T; Maeda M
Sensors (Basel); 2015 May; 15(5):11972-87. PubMed ID: 26007739
[TBL] [Abstract][Full Text] [Related]
19. Kallikrein-related peptidase 13: an independent indicator of favorable prognosis for patients with nonsmall cell lung cancer.
Gueugnon F; Barascu A; Mavridis K; Petit-Courty A; Marchand-Adam S; Gissot V; Scorilas A; Guyetant S; Courty Y
Tumour Biol; 2015 Jul; 36(7):4979-86. PubMed ID: 25677900
[TBL] [Abstract][Full Text] [Related]
20. Correlation between KLK6 expression and the clinicopathological features of glioma.
Lou J; Si H; Chen Y; Sun X; Zhang H; Niu A; Hu C
Contemp Oncol (Pozn); 2014; 18(4):246-51. PubMed ID: 25258582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
